<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:40:39Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3107995" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3107995</identifier><datestamp>2011-06-06</datestamp><setSpec>molvis</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Vis</journal-id>
      <journal-id journal-id-type="publisher-id">MV</journal-id>
      <journal-title-group>
        <journal-title>Molecular Vision</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1090-0535</issn>
      <publisher>
        <publisher-name>Molecular Vision</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3107995</article-id>
      <article-id pub-id-type="pmcid">PMC3107995</article-id>
      <article-id pub-id-type="pmc-uid">3107995</article-id>
      <article-id pub-id-type="pmid">21647268</article-id>
      <article-id pub-id-type="publisher-id">149</article-id>
      <article-id pub-id-type="publisher-id">2011MOLVIS0165</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Identification of differentially expressed genes in uveal melanoma using suppressive subtractive hybridization</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Landreville</surname>
            <given-names>Solange</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lupien</surname>
            <given-names>Caroline B.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vigneault</surname>
            <given-names>Francois</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gaudreault</surname>
            <given-names>Manon</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mathieu</surname>
            <given-names>MÃ©lissa</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rousseau</surname>
            <given-names>Alain P.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>GuÃ©rin</surname>
            <given-names>Sylvain L.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Salesse</surname>
            <given-names>Christian</given-names>
          </name>
        </contrib>
        <aff id="aff1">LOEX/CUO recherche,Â Centre hospitalier affiliÃ© universitaire de QuÃ©bec,Â HÃ´pital du Saint-Sacrement, andÂ DÃ©partement dâophtalmologie, FacultÃ© de mÃ©decine, UniversitÃ© Laval,Â QuÃ©bec, QuÃ©bec, Canada</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Correspondence to: Dr. Christian Salesse,Â LOEX/CUO recherche,Â Centre hospitalier affiliÃ© universitaire de QuÃ©bec,Â HÃ´pital du Saint-Sacrement,Â Bureau K2-02,Â 1050 Chemin Ste-Foy,Â QuÃ©bec, QuÃ©bec, Canada, G1S 4L8;Â Phone: 418-682-7569;Â FAX: 418-682-8000; email: <email xlink:href="Christian.Salesse@fmed.ulaval.ca">Christian.Salesse@fmed.ulaval.ca</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <fpage>1324</fpage>
      <lpage>1333</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>4</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>5</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2011 Molecular Vision.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open-access article distributed under the terms of the
        Creative Commons Attribution License, which permits unrestricted use,
        distribution, and reproduction in any medium, provided the original
        work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>Uveal melanoma (UM) is the most common primary cancer of the eye, resulting not only in vision loss, but also in metastatic death. This study attempts to identify changes in the patterns of gene expression that lead to malignant transformation and proliferation of normal uveal melanocytes (UVM) using the Suppressive Subtractive Hybridization (SSH) technique.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>The SSH technique was used to isolate genes that are differentially expressed in the TP31 cell line derived from a primary UM compared to UVM. The expression level of selected genes was further validated by microarray, semi-quantitative RTâPCR and western blot analyses.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Analysis of the subtracted libraries revealed that 37 and 36 genes were, respectively, up- and downregulated in TP31 cells compared to UVM. Differential expression of the majority of these genes was confirmed by comparing UM cells with UVM by microarray. The expression pattern of selected genes was analyzed by semi-quantitative RTâPCR and western blot, and was found to be consistent with the SSH findings.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>We demonstrated that the SSH technique is efficient to detect differentially expressed genes in UM. The genes identified in this study represent valuable candidates for further functional analysis in UM and should be informative in studying the biology of this tumor.</p>
        </sec>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>GalleyStatus</meta-name>
          <meta-value>Export to XML</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>corr-author</meta-name>
          <meta-value>Salesse</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Uveal melanoma (UM) is a malignant tumor that arises from neural crest-derived melanocytes of the uveal tract of the eye [<xref ref-type="bibr" rid="r1">1</xref>]. It is the most prevalent primary cancer of the eye with an annual frequency of 4â7 cases per million of population in North America [<xref ref-type="bibr" rid="r1">1</xref>]. This ocular tumor not only has the capacity to destroy vision but can also metastasize and ultimately cause death in up to half of patients diagnosed with this type of cancer. Despite chemotherapy, the metastatic disease is fatal, usually within a few months of diagnosis [<xref ref-type="bibr" rid="r1">1</xref>].</p>
      <p>Carcinogenesis occurs as an accumulation of molecular events involving disruption of cell cycle and apoptotic control, as well as increased aneuploidy leading ultimately to malignant transformation and dissemination of tumor cells. In the past decade, many details of the pathogenesis of UM have emerged, e.g., the gene-expression signatures with prognostic significance, as well as guanine nucleotide-binding proteins alpha-q and alpha 11 (<italic>GNAQ/GNA11</italic>) and BRCA1 associated protein-1 (<italic>BAP1</italic>) mutations [<xref ref-type="bibr" rid="r2">2</xref>-<xref ref-type="bibr" rid="r5">5</xref>]. Despite these discoveries, a better insight into tumor progression of UM primary tumors remains of utmost importance to identify new therapeutic targets. One way to better understand the malignant transformation of cells is to determine which genes are differentially expressed between primary tumors and normal melanocytes.</p>
      <p>The suppressive subtractive hybridization (SSH) technique, a combination of subtraction and kinetic enrichment coupled to subsequent amplification, increases the representation of rare mRNAs, which enables to compare two different populations of mRNAs and to obtain clones of genes that are differentially expressed in the population of interest [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>]. This technique has proven to be useful in identifying tissue-specific and less abundant transcripts as it can achieve over a 1,000 fold enrichment for differentially expressed cDNA populations [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r8">8</xref>]. Here, we describe the identification of 73 genes differentially expressed in primary UM using the SSH technique. Some of these genes are likely involved in malignant transformation and should be informative in studying the biology of UM.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>This study followed the principles of the Declaration of Helsinki and was approved by our institutional human experimentation committee. Written informed consent was obtained from the enucleated subjects.</p>
      <sec>
        <title>Tissue collection and cell culture</title>
        <p>The TP31 cell line is derived from a mixed epitheloid-spindle primary UM tumor of a 62-year-old patient that died of liver metastases (<xref ref-type="table" rid="t1">Table 1</xref>) [<xref ref-type="bibr" rid="r9">9</xref>]. This cell line does not have mutations in <italic>GNAQ</italic> or <italic>GNA11</italic> and was cultured in DMEM/F12 medium (Gibco BRL, Burlington, ON) supplemented with 10% FBS (Gemini; NorthBio, Toronto, ON) under 5% CO<sub>2</sub>. Normal uveal melanocytes (UVM) were grown from human donor eyes provided by the Banque dâYeux Nationale (CHUL, QuÃ©bec, QC), according to the procedure described by Hu et al. [<xref ref-type="bibr" rid="r10">10</xref>]. Samples of UM primary tumors were collected at the time of enucleation (<xref ref-type="table" rid="t1">Table 1</xref>) and were either immediately stored at â80Â Â°C in Tri-Reagent for RNA extraction (Sigma-Aldrich, Oakville, ON) or grown in tissue culture for less than 9 passages [<xref ref-type="bibr" rid="r9">9</xref>]. Tumors were classified according to a modification of the Callenderâs classification [<xref ref-type="bibr" rid="r11">11</xref>].</p>
        <table-wrap id="t1" position="float">
          <label>Table 1</label>
          <caption>
            <title>Clinicopathological characteristics and survival data of uveal melanoma cases.</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="36" span="1"/>
            <col width="58" span="1"/>
            <col width="51" span="1"/>
            <col width="137" span="1"/>
            <col width="72" span="1"/>
            <col width="65" span="1"/>
            <thead>
              <tr>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>#</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Age, Sex</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Size</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Last status</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Follow-up* (months)</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Pathology</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">TP31<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">62, M<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Large<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Dead of metastasis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">42<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Mixed<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">69, M<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Large<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Alive without metastasis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">104<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Mixed<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">33, M<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Large<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Alive without metastasis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">104<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Spindle<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">3<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">45, M<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Medium<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Alive without metastasis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">81<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Spindle<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">4<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">34, F<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Medium<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Alive without metastasis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">103<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Spindle<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">5<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">69, M<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Small<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Alive without metastasis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">57<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Spindle<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">6</td>
                <td valign="top" align="center" rowspan="1" colspan="1">46, M</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Large</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Dead of metastasis</td>
                <td valign="top" align="center" rowspan="1" colspan="1">18</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Epithelioid</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>*Follow-up: period from enucleation until patient death or last visit.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Suppressive subtractive hybridization (SSH)</title>
        <p>Total RNA derived from both the TP31 cell line and UVM (pool of 18 donors) was extracted with the RNeasy kit (Qiagen, Mississauga, ON) and mRNA was isolated with the Oligotex mRNA kit (Qiagen) according to the manufacturerâs instructions. cDNA was synthesized using the SMART PCR cDNA Synthesis kit (Clontech Laboratories, Mountain View, CA). Two SSH libraries were then performed between the TP31 cell line and UVM (a forward subtraction named âTP31 cell line subtracted libraryâ and a reverse one named âUVM subtracted libraryâ) using the PCR-Select cDNA Subtraction kit (Clontech Laboratories) according to the procedure described by Diatchenko et al. [<xref ref-type="bibr" rid="r7">7</xref>]. In the forward subtraction, the TP31 cell line was used as the tester and UVM as the driver (TP31 cell line subtracted library, which corresponds to upregulated genes in the TP31 cell line) whereas the UVM were used as the tester and the TP31 cell line as the driver in the reverse subtraction (UVM subtracted library, which corresponds to downregulated genes in the TP31 cell line). To evaluate the efficiency of the cDNA subtraction, the expression level of actin and endothelin receptor type B (<italic>EDNRB</italic>; <xref ref-type="table" rid="t2">Table 2</xref>) was monitored by RTâPCR in subtracted cDNA and unsubtracted cDNA. Aliquots of subtracted and unsubtracted cDNAs were removed from each reaction after 18, 23, 28, and 33 cycles and compared by agarose gel electrophoresis.</p>
        <table-wrap id="t2" position="float">
          <label>Table 2</label>
          <caption>
            <title>Sequence of forward and reverse primers used for PCR amplification.</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="54" span="1"/>
            <col width="190" span="1"/>
            <col width="187" span="1"/>
            <col width="104" span="1"/>
            <thead>
              <tr>
                <th valign="top" align="left" scope="col" rowspan="1" colspan="1">
                  <bold>Gene</bold>
                </th>
                <th valign="top" align="left" scope="col" rowspan="1" colspan="1">
                  <bold>Forward primer (5â²-3â²)</bold>
                </th>
                <th valign="top" align="left" scope="col" rowspan="1" colspan="1">
                  <bold>Reverse primer (5â²-3â²)</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Expected PCR product size (bp)</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>Actin</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">TGTCCACCTTCCAGCAGATGT<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">CACTCCCAGGGAGACCAAAA<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">609<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>ANLN</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">CCAAGTCCTGTGTCCTCA<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">TGTCCCTCACAACTTTTAGCA<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">643<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>ANP32E</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">CGCGCTAGTGTGTGGACAAG<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">CGGCGCTTCATTATCCTCCT<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">700<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>CKAP5</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">CAGTGAGTGGTTGAAACTGCC<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">CTCCAGGGCCTCTTTTCTC<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">895<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>CTSK</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">ACCCCGGTTCTTCTGCACAT<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">GCCGAGGTACCCCTGTCTCA<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">306<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>DTL</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">CTTGGCGTCCTGAGAAATGG<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">TGGAAATCCACAGAAGGAGCA<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">614<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>EDNRB</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">CCAACATGTGGCCCAGCCTA<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">TGAGGTGGGGTTGGAGGAAA<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">231<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>MTAP</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">AGTAGCATGGCTGCCCAGGA<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">CCCTCCACCCTTTATTGTTGC<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">310<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>PPP3CA</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">AGGCAATTGATCCCAAGTTGT<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">GGGGTAGAGAATTTTCAAGGC<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">409<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>TSPYL5</italic>
                  <hr/>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">AGATGCAAGGGAAAGGAAGCA<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">CTCGGACCCCATGTGTCCAT<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">323<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <italic>TYRP1</italic>
                </td>
                <td valign="top" align="left" rowspan="1" colspan="1">ACCGCTGTGGCTCATCATCA</td>
                <td valign="top" align="left" rowspan="1" colspan="1">TCCCCGTTGCAAAATTCCAG</td>
                <td valign="top" align="center" rowspan="1" colspan="1">603</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Cloning, differential screening, sequencing and analysis of the subtracted cDNAs</title>
        <p>The PCR products of the SSH libraries were purified (NucleoSpin Extract kit; Clontech Laboratories) and then inserted into the T/A cloning vector pGEM-T Easy (Promega, Madison, WI). Individual transformants carrying subtracted cDNA fragments were isolated from white colonies and used for differential screening (PCR-Select Differential Screening kit; Clontech Laboratories) to eliminate false positives, according to the manufacturerâs instructions. PCR fragments of the positive clones were isolated with QIAquick PCR Purification kit (Qiagen) and then sequenced using Nested PCR Primers 1 and 2R (Clontech Laboratories) with an automated DNA sequencer (ABI Prism model 3900; Applied Biosystems, Foster City, CA). DNA sequencing of positive clones was performed by the Plateforme de sÃ©quenÃ§age et de gÃ©notypage des gÃ©nomes at UniversitÃ© Laval (QuÃ©bec, QC). The inserted sequences were examined for similarities to human genes with the <ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/">NCBI BLAST</ext-link> program. Poly (A)<sup>+</sup>, vector sequences, and sequences with many ambiguities were manually removed from the sequence data. A sequence was considered significant to a database entry when an aligned region was more than 95% identical over the entire cDNA length.</p>
      </sec>
      <sec>
        <title>Microarray gene expression profiling</title>
        <p>Gene expression profiling was performed as previously reported [<xref ref-type="bibr" rid="r12">12</xref>] using HumanHT-12 v3 Expression BeadChip arrays (48,804 probes; Illumina, San Diego, CA). Data were analyzed using the ArrayStar v3.0 software (DNASTAR, Madison, WI).</p>
      </sec>
      <sec>
        <title>Semi-quantitative RTâPCR</title>
        <p>Total RNA derived from the TP31 cell line, as well as from UVM was extracted with the RNeasy kit (Qiagen) as described above. Total RNA derived from uncultured UM primary tumors was isolated using Tri-Reagent (Sigma-Aldrich, Oakville, ON) according to the manufacturerâs instructions. Reverse transcription was performed using random hexamer primers following manufacturerâs protocol for synthesis of first strand cDNA (MBI Fermentas, Burlington, ON). Primers (<xref ref-type="table" rid="t2">Table 2</xref>) were designed using the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/genbank/">GenBank</ext-link> database (NCBI, Bethesda, MD). Semi-quantitative RTâPCR was performed as described previously [<xref ref-type="bibr" rid="r13">13</xref>] using the QuantumRNA 18S Internal standards protocol (Ambion, Austin, TX) according to the manufacturerâs instructions.</p>
      </sec>
      <sec>
        <title>SDSâPAGE and western blot</title>
        <p>Protein extraction and SDSâPAGE/western blot were performed as described previously [<xref ref-type="bibr" rid="r14">14</xref>]. Proteins were separated on 10% polyacrylamide gels, transferred onto a nitrocellulose membrane (Biorad, Hercules, CA) and incubated with antibodies directed against Î²-actin (loading control; mouse, 0.025Â Âµg/ml; Cedarlane, Hornby, ON), anillin (ANLN; rabbit, 1.0Â Âµg/ml; kindly provided by Dr. Peter A. Hall, Queens University, Belfast, Ireland), protein phosphatase 3 catalytic subunit alpha isoform (PPP3CA; rabbit, 1.0Â Âµg/ml; Chemicon, Temecula, CA) and tyrosinase-related protein 1 (TYRP1; rabbit, 0.08Â Âµg/ml; Santa Cruz Biotechnology, Santa Cruz, CA). The blots were visualized using the Fluor-S Max System (Biorad, Hercules, CA) after incubation with peroxidase-conjugated secondary antibodies.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Evaluation of subtraction efficiency</title>
        <p>Successful SSH should decrease housekeeping gene transcripts abundance and enrich tissue-specific gene transcripts [<xref ref-type="bibr" rid="r6">6</xref>]. A reduction of actin mRNA expression can be observed in the TP31 subtracted library compared to the unsubtracted TP31 cDNA. Indeed, the actin amplicon can be observed after 23 cycles of amplification in the subtracted library compared to 18 cycles for the unsubtracted population (<xref ref-type="fig" rid="f1">Figure 1A</xref>). A similar reduction of actin mRNA expression was observed in the UVM subtracted library (<xref ref-type="fig" rid="f1">Figure 1B</xref>). As a positive control for the enrichment of differentially expressed genes, <italic>EDNRB,</italic> a melanocytic lineage marker was amplified. <italic>EDNRB</italic> amplicon can be observed after 18 cycles in the UVM subtracted library compared to 33 cycles for the unsubtracted population (<xref ref-type="fig" rid="f1">Figure 1C</xref>). These data demonstrate successful subtractions, with significant reduction of actin abundance and significant enrichment of <italic>EDNRB</italic>, 5 cycles corresponding roughly to a 20-fold cDNA concentration difference.</p>
        <fig id="f1" fig-type="figure" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Evaluation of the subtraction efficiency by PCR using the housekeeping gene actin and the melanocyte marker <italic>EDNRB</italic>. <bold>A</bold>: Reduction of actin expression in the TP31 subtracted library compared to unsubtracted TP31 cDNA. <bold>B</bold>: Reduction of actin expression in the UVM subtracted library compared to unsubtracted UVM cDNA. <bold>C</bold>: Enrichment of <italic>EDNRB</italic> expression in the UVM subtracted library compared to unsubtracted UVM cDNA. Samples were taken after 18, 23, 28, and 33 PCR cycles.</p>
          </caption>
          <graphic xlink:href="mv-v17-1324-f1"/>
        </fig>
      </sec>
      <sec>
        <title>Comparison of mRNA profiles between uveal melanoma and normal uveal melanocytes using SSH</title>
        <p>The analysis of the TP31 cell line subtracted library (UM upregulated genes) showed that 58 positive clones corresponded to 37 genes when taking the redundancy into account (<xref ref-type="table" rid="t3">Table 3</xref>). 57% of these genes were previously associated with cancer (highlighted in bold in <xref ref-type="table" rid="t3">Table 3</xref>). The most highly represented genes in this subtracted library were anillin (<italic>ANLN</italic>) and the cytoskeleton associated protein 5 (<italic>CKAP5</italic>). Analysis of the UVM subtracted library (UM downregulated genes) showed that 54 positive clones corresponded to 36 genes when taking the redundancy into account (<xref ref-type="table" rid="t4">Table 4</xref>). Among these genes, 55% were previously found to be downregulated in cancer (highlighted in bold in <xref ref-type="table" rid="t4">Table 4</xref>). The most highly represented genes in the UVM subtracted library were actin gamma 1 (<italic>ACTG1</italic>), alpha-2-macroglobuline (<italic>A2M</italic>), cathepsin K (<italic>CTSK</italic>), and proteolipid protein 1 (<italic>PLP1</italic>). Comparison with microarray data of the previously published transcriptome of UVM [<xref ref-type="bibr" rid="r12">12</xref>] confirmed an upregulation of 70% of the genes identified in the TP31 cell line subtracted library and a downregulation of 81% of the genes identified in the UVM subtracted library (<xref ref-type="table" rid="t3">Table 3</xref> and <xref ref-type="table" rid="t4">Table 4</xref>, last column). The most represented biologic processes were associated to cell division and metabolism for the upregulated genes, while they were linked to differentiation and G-protein signaling for the downregulated genes.</p>
        <table-wrap id="t3" position="float">
          <label>Table 3</label>
          <caption>
            <title>Upregulated genes from the TP31 cell line subtracted library.</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="549" span="1"/>
            <col width="83" span="1"/>
            <col width="90" span="1"/>
            <col width="182" span="1"/>
            <col width="75" span="1"/>
            <col width="70" span="1"/>
            <thead>
              <tr>
                <th valign="top" align="left" scope="col" rowspan="1" colspan="1">
                  <bold>Gene</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Chromosomal location</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>GenBank accession #</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Biological process</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Redundancy</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Microarray fold-change UM/UVM*</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Acidic (leucine-rich) nuclear phosphoprotein 32 member E (ANP32E)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1q21.2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_030920</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Apoptosis</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.59</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Alkylglycerone phosphate synthase (AGPS)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2q31.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_003659<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Lipid metabolism<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2.85<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Anillin actin binding protein (ANLN)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>7p14</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_018685</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Cell division</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>4</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.69</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">ATP synthase H<sup>+</sup> transporting mitochondrial F0 complex subunit G (ATP5L)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">11q23.3<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_006476<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">ATP synthesis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">11.20<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Calumenin (CALU)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>7q32.1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_001219</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Calcium ion binding</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.43</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chromosome 6 open reading frame 211 (C6orf211)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">6q25.1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_024573<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.72<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chromosome 6 open reading frame 62 (C6orf62)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">6p22.3<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_030939<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.43<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chromosome 7 open reading frame 64 (C7orf64)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">7q21.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_032120<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.53<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Cytoskeleton associated protein 5 (CKAP5)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>11p11.2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_014756</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Cell division</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>5</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>4.13</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Denticleless homolog (DTL)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1q32</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_016448</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Protein ubiquitination</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>3.79</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Family with sequence similarity 126 member B (FAM126B)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2q33.1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_173822<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.28<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Family with sequence similarity 35 member A (FAM35A)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">10q23.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_019054<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.02<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Family with sequence similarity 63 member B (FAM63B)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">15q21.3<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_001040450<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.92<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Glutamate-ammonia ligase (GLUL)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1q31</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_002065</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Cell proliferation</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.65</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">HEAT repeat containing 5A (HEATR5A)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">14q12<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_015473<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.63<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Histone deacetylase 3 (HDAC3)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>5q31</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_003883</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Chromatin modification</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>3.03</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Human T-cell leukemia virus type 1 binding protein 1 (TAX1BP1)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>7p15</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_006024</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Apoptosis</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2.03</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Integrin alpha 6 subunit (ITGA6)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2q31.1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_000210</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Cell adhesion</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.68</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Interleukin 1 receptor antagonist (IL1RN)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2q14.2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_173842</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Inflammatory response</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>5</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.71</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">KIAA2018<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">3q13.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_001009899<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.62<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Melanocortin 3 receptor (MC3R)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">20q13.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_019888<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">G-protein signaling<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.81<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Microphthalmia-associated transcription factor (MITF)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">3p14.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_198159<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Melanocyte differentiation<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.48<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Multiple coagulation factor deficiency protein 2 (MCFD2)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2p21</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_139279</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Vesicule-mediated transport</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.37</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>MutL homolog 3 (MLH3)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>14q24.3</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_014381</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>DNA repair</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.43</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Oligosaccharyltransferase complex subunit (OSTC)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">4q25<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_021227<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Protein glycosylation<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.31<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Peroxisome proliferator-activated receptor gamma coactivator 1 (PPARGC1)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>4p15.1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_013261</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Cellular respiration</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.51</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Pleckstrin homology domain containing family A member 8 (PLEKHA8)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>7p21-p11.2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_032639</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Protein transport</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.38</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Potassium voltage-gated channel, Shab-related subfamily member 1 (KCNB1)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">20q13.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_004975<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Potassium ion transport<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.84<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Proteasome 26S subunit non-ATPase 2 (PSMD2)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>3q27.1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_002808</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Protein ubiquitination</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.40</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Proteasome maturation protein (POMP)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>13q12.3</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_015932</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Proteasome assembly</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>3.16</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Protein phosphatase 3 catalytic subunit alpha isozyme (PPP3CA)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>4q24</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_000944</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Protein phosphorylation</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.51</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Required for meiotic nuclear division 5 homolog A (RMND5A)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2p11.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_022780<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Cell division<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.77<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Topoisomerase (DNA) II alpha (TOP2A)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>17q21-q22</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_001067</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>DNA replication</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>19.52</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Translocase of inner mitochondrial membrane 17 homolog A (TIMM17A)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1q32.1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_006335</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Mitochondrial protein transport</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1.63</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta polypeptide (YWHAB)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>20q13.1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_003404</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Ras signal transduction</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>4.00</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Vaccinia related kinase 1 (VRK1)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>14q32</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_003384</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Protein phosphorylation</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>6.53</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Zinc finger, HIT-type containing 6 (ZNHIT6)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1p22.3</td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_017953</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Ribosome biogenesis</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3.89</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>*Considerated validated if the UM/UVM fold-change was &gt;1.5. Genes highlighted in bold were previously shown to be upregulated in cancer.</p>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="t4" position="float">
          <label>Table 4</label>
          <caption>
            <title>Downregulated genes from the UVM subtracted library.</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="400" span="1"/>
            <col width="83" span="1"/>
            <col width="90" span="1"/>
            <col width="163" span="1"/>
            <col width="75" span="1"/>
            <col width="70" span="1"/>
            <thead>
              <tr>
                <th valign="top" align="left" scope="col" rowspan="1" colspan="1">
                  <bold>Gene</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Chromosomal location</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>GenBank accession#</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Biological process</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Redundancy</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Microarray fold-change UM/UVM*</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Actin gamma 1 (ACTG1)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>17q25.3</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_001614</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Motility</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>3</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â86.7</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>A kinase (PRKA) anchor protein 12 (AKAP12)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>6q25</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_005100</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>G-protein signaling</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â1.91</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Alpha-2-macroglobuline (A2M)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>12p13.31</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_000014</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Cytokine transport</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>3</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â44.4</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cathepsin K (CTSK)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1q21<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_000396<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Proteolysis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">3<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â106.5<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chromosome 1 open reading frame 124 (C1orf124)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1q42<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_032018<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">DNA repair<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â0.62<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chromosome 18 open reading frame 32 (C18orf32)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">18q21.1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_001035005<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NF-kappaB cascade regulation<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â2.69<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Dynein cytoplasmic 1 light intermediate chain 2 (DYNC1LI2)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">16q22.1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_006141<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Endosome transport<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â2.61<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>E74-like factor 1 (ets domain transcription factor) (ELF1)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>13q13</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_172373</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Transcription</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â1.83</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Endothelin receptor type B (EDNRB)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>13q22</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_000115</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Melanocyte differentiation</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â38.9</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Epithelial membrane protein 1 (EMP1)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>12p12.3</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_001423</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Epithelial cell differentiation</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â148.8</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Formin binding protein 4 (FNBP4)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">11p11.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_015308<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â7.82<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Glycoprotein (transmembrane) nmb (GPNMB)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>7p15</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_002510</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Melanocyte differentiation</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â84.5</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Guanine nucleotide binding protein alpha inhibiting polypeptide 3 (GNAI3)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1p13</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_006496</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>G-protein signaling</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â0.82</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Guanine nucleotide binding protein (G protein) gamma 11 (GNG11)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>7q21</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_004126</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>G-protein signaling</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â6.56</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Heterochromatin protein 1 binding protein 3 (HP1BP3)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1p36.12<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_016287<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Nucleosome assembly<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â2.37<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Importin 7 (IPO7)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">11p15.4<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_006391<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Protein transport<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â0.64<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Junction mediating and regulatory protein p53 cofactor (JMY)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">5q14.1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_152405<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Apoptosis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â1.68<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Leucine rich repeat containing 39 (LRRC39)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1p21.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_144620<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â3.90<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Lysophosphatidic acid receptor 6 (LPAR6)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>13q14</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_005767</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>G-protein signaling</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â20.7</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Methylthioadenosine phosphorylase (MTAP)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>9p21</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_002451</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Polyamine metabolism</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â2.55</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Nerve growth factor receptor associated protein 1 (NGFRAP1)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Xq22.2</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_206915</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Apoptosis</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â2.45</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Potassium channel tetramerisation domain containing 18 (KCTD18)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2q33.1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_152387<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Potassium ion transport<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â1.33<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Potassium inwardly-rectifying channel subfamily J member 13 (KCNJ13)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2q37<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_002242<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Potassium ion transport<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â21.9<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Proteolipid protein 1 (PLP1)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Xq22</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_000533</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Glial cell differentiation</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>4</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â5.78</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Rho-related BTB domain-containing protein 3 (RHOBTB3)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>5q15</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_014899</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Retrograde transport</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â2.69</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ribosomal protein S6 kinase polypeptide 1 (RPS6KC1)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1q41<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_012424<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Protein phosphorylation<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â1.64<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">SLIT and NTRK-like family member 2 (SLITRK2)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Xq27.3<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_032539<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Axonogenesis<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â2.51<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>SRY (sex determining region Y)-box 4 (SOX4)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>6p22.3</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_003107</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Transcription</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â1.26</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Subunit of the oligosaccharyltransferase complex homolog B (STT3B)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">3p23<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_178862<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Protein glycosylation<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â1.50<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Transcription elongation factor A (SII)-like 7 (TCEAL7)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Xq22.1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_152278</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Transcription</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â2.82</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Transmembrane emp24 protein transport domain containing 7 (TMED7)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">5q22.3<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_181836<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">ER transport<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â1.15<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Testis-specific protein-like 1, y-encoded (TSPYL5)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>8q22.1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_033512</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Nucleosome assembly</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â4.02</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Tyrosinase-related protein 1 (TYRP1)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>9p23</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_000550</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Melanocyte differentiation</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â397</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Ubiquitin-conjugating enzyme E2H (UBE2H)</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>7q32</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_003344</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Protein ubiquitination</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>1</bold>
                  <hr/>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>â2.32</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">WW domain binding protein 5 (WBP5)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Xq22.2<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">NM_016303<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">Unknown<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">â2.54<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Zinc finger AN1-type domain 5 (ZFAND5)</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>9q21</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>NM_006007</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>Development</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>2</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.61</bold>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>*Considerated validated if the UM/UVM fold-change was &lt;-1.5. Genes highlighted in bold were previously shown to be downregulated in cancer.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Validation of selected up- and downregulated genes by semi-quantitative RTâPCR and western blot</title>
        <p>Semi-quantitative RTâPCR analyses were performed to compare the expression of the upregulated genes acidic nuclear phosphoprotein 32 member E (<italic>ANP32E</italic>), <italic>CKAP5</italic>, and denticleless homolog (<italic>DTL</italic>) from the TP31 cell line subtracted library (<xref ref-type="fig" rid="f2">Figure 2A</xref>), as well as the downregulated genes <italic>CTSK</italic>, methylthioadenosine phosphorylase (<italic>MTAP</italic>), and testis-specific protein-like 1 y-encoded (<italic>TSPYL5</italic>) from the UVM subtracted library (<xref ref-type="fig" rid="f2">Figure 2B</xref>) between the TP31 cell line, UM primary tumors, and UVM. These genes were chosen for their redundancy in the SSH libraries and/or their implication in malignant melanoma or other cancers, after microarray validation. These analyses showed identical expression patterns as those revealed by the SSH technique, indicating that the SSH data were accurate. Indeed, no band could be seen in the UVM for the upregulated genes (<xref ref-type="fig" rid="f2">Figure 2A</xref>). In addition, no band could be observed in the TP31 cell line and UM primary tumors for the downregulated genes (<xref ref-type="fig" rid="f2">Figure 2B</xref>). We next examined both mRNA and protein expression of <italic>ANLN</italic> and <italic>TYRP1</italic> between TP31 cell line, UM primary tumors, and UVM (<xref ref-type="fig" rid="f3">Figure 3</xref>). Neither mRNA nor protein could be detected for <italic>ANLN</italic> in UVM compared to TP31 and some primary tumors (<xref ref-type="fig" rid="f3">Figure 3A</xref>). <italic>TYRP1</italic> mRNA and protein level were greatly decreased in TP31 cell line and primary tumors compared to UVM (<xref ref-type="fig" rid="f3">Figure 3B</xref>). In addition, <italic>PPP3CA</italic> mRNA or protein was not detected in UVM compared to TP31 and primary tumors (<xref ref-type="fig" rid="f4">Figure 4</xref>). Moreover, we identified a new splice variant of <italic>PPP3CA</italic> in the TP31 cell line as well as in the primary tumors. This shorter amplicon was not expressed by the UVM (<xref ref-type="fig" rid="f4">Figure 4A</xref>, lower band). The sequencing of this amplicon allowed the identification of a new splice variant of <italic>PPP3CA</italic> lacking exon 2 (<italic>PPP3CAÎ2</italic>). Western blots were performed to confirm the existence of a splice variant of the PPP3CA protein using an antibody raised against exon 1 to assess the expression of both the native protein and the splice variant lacking exon 2. As can be seen in <xref ref-type="fig" rid="f4">Figure 4B</xref> (left panel), two protein products were detected at 51- and 59-kDa in the extracts prepared from both the TP31 cell line and a pool of UM primary tumor protein extracts, but not in UVM. When using several UM primary tumors separately, some expressed both the native PPP3CA protein and the splice variant, while others expressed only the splice variant (<xref ref-type="fig" rid="f4">Figure 4B</xref>, right panel).</p>
        <fig id="f2" fig-type="figure" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Validation of upregulated and downregulated genes identified in the subtracted libraries. The mRNA expression level of selected genes was measured by semi-quantitative RTâPCR in the TP31 cell line, a pool of RNA from uncultured UM primary tumors (Tumors) and UVM. <bold>A</bold>: Upregulated genes identified in the TP31 subtracted library (<italic>ANP32E</italic>, <italic>CKAP5</italic>, <italic>DTL</italic>). <bold>B</bold>: Downregulated genes identified in the UVM subtracted library (<italic>CTSK</italic>, <italic>MTAP</italic>, <italic>TSPYL5</italic>). The 18S rRNA was used as an internal control of amplification (489 bp). Data are representative of three independent experiments.</p>
          </caption>
          <graphic xlink:href="mv-v17-1324-f2"/>
        </fig>
        <fig id="f3" fig-type="figure" position="float">
          <label>Figure 3</label>
          <caption>
            <p><italic>ANLN</italic> and <italic>TYRP1</italic> expression in UM. <bold>A</bold>: The expression level of <italic>ANLN</italic> was measured by semi-quantitative RTâPCR (left panel) and western blot (right panel) in the TP31 cell line, UM primary tumors (Tumors), and UVM. <bold>B</bold>: The expression level of <italic>TYRP1</italic> was measured by semi-quantitative RTâPCR (left panel) and western blot (right panel) in UVM, the TP31 cell line and UM primary tumors (Tumors). The 18S rRNA was used as an internal control of amplification (489 bp). Actin was used as a protein loading control. Data are representative of three independent experiments.</p>
          </caption>
          <graphic xlink:href="mv-v17-1324-f3"/>
        </fig>
        <fig id="f4" fig-type="figure" position="float">
          <label>Figure 4</label>
          <caption>
            <p><italic>PPP3CA</italic> expression in UM. <bold>A</bold>: The expression level of <italic>PPP3CA</italic> mRNA was measured by semi-quantitative RTâPCR in the TP31 cell line, UM primary tumors (Tumors), and UVM. <bold>B</bold>: The expression level of the PPP3CA protein was measured by western blot in the TP31 cell line, UVM, and UM primary tumors (left panel: pool of protein extracts from UM primary tumors; right panel: individual UM primary tumors). A new splice variant was detected, which lacks parts of the NH<sub>2</sub>-terminal and catalytic domains after the deletion of exon 2 (PPP3CAÎ2). The 18S rRNA was used as internal control of amplification (489 bp). Actin was used as a protein loading control. Data are representative of three independent experiments.</p>
          </caption>
          <graphic xlink:href="mv-v17-1324-f4"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Only a few oncogenes involved in the development of UM primary tumors have been discovered until now. This study was undertaken to identify additional genes that could be required for malignant transformation of melanocytes by preparing subtracted libraries using normal UVM and the UM cell line TP31. The sequencing of upregulated cDNAs from the TP31 cell line subtracted library and downregulated cDNAs from the UVM subtracted library has resulted in the identification of 73 genes differentially expressed by UM.</p>
      <p>Many genes found to be upregulated in the TP31 cell line subtracted library were previously associated with cancer, including <italic>ANLN</italic> and <italic>PPP3CA</italic>. ANLN is an actin binding protein that can associate with septins and is involved in cytokinesis [<xref ref-type="bibr" rid="r15">15</xref>]. Several studies have demonstrated an overexpression of <italic>ANLN</italic> in cancer such as in several of the UM tumors assayed in the present study. Indeed, Hall et al. assessed <italic>ANLN</italic> expression in several human tissue samples and cell lines by microarray analyses and demonstrated that the median level of <italic>ANLN</italic> expression was higher in tumors than in normal tissues and correlated with the metastatic potential of these tumors [<xref ref-type="bibr" rid="r16">16</xref>]. Moreover, <italic>ANLN</italic> overexpression was shown to increase levels of active RhoA and subsequently cell motility [<xref ref-type="bibr" rid="r16">16</xref>]. Therefore, given that increased genomic instability is a feature of metastatic UM tumors [<xref ref-type="bibr" rid="r1">1</xref>], <italic>ANLN</italic> overexpression could create defects in cytokinesis leading to binucleation and genomic instability. Calcineurin is a protein phosphatase regulating the Ca<sup>2+</sup>/calmodulin complex, formed by a catalytic A subunit (PPP3CA) and a regulatory B subunit [<xref ref-type="bibr" rid="r17">17</xref>]. Whereas interest was previously confined to its activity in immune response, calcineurin is now becoming recognized as a predominant participant in oncogenesis [<xref ref-type="bibr" rid="r18">18</xref>]. Indeed, the Ca<sup>2+</sup>/calcineurin/ nuclear factor of activated T-cells (NFAT) signaling pathway influences different aspects of tumor biology, such as stimulation of angiogenesis through upregulation of vascular endothelial growth factor (VEGF), tumor cell proliferation through upregulation of myelocytomatosis oncogene (MYC), and tumor cell migration through cyclooxygenase-2 (COX-2) [<xref ref-type="bibr" rid="r18">18</xref>]. Native PPP3CA contains five distinct domains: the NH<sub>2</sub>-terminal, the catalytic, the B-subunit binding, the calmodulin-binding and the auto-inhibitory domains [<xref ref-type="bibr" rid="r17">17</xref>]. Three variants were identified previously and one splice variant showed no phosphatase activity, but was able to stimulate the phosphatase activity of the native protein, thus rendering PPP3CA more calcium-sensitive [<xref ref-type="bibr" rid="r19">19</xref>]. In the present study, we reported the expression of a novel PPP3CA splice variant in primary UM cells that lacks part of the NH<sub>2</sub>-terminus and catalytic domains (PPP3CAÎ2; GenBank#AY904364; <xref ref-type="fig" rid="f4">Figure 4</xref>). Further biochemical analysis will be necessary to determine whether or not the catalytic activity of this new variant is altered.</p>
      <p>Among the genes found to be downregulated in the UVM subtracted library, several were previously associated with melanoma, such as melanocytic markers <italic>TYRP1</italic>, <italic>EDNRB</italic>, <italic>MTAP</italic>, and sex determining region Y box 4 (<italic>SOX4</italic>; <xref ref-type="table" rid="t4">Table 4</xref>). Indeed, the expression of <italic>TYRP1</italic> was inversely correlated with tumor stage in malignant melanoma [<xref ref-type="bibr" rid="r20">20</xref>]. A decreased expression of <italic>EDNRB</italic> was previously associated with early metastasis and short survival in UM [<xref ref-type="bibr" rid="r21">21</xref>]. A tissue microarray study in malignant melanoma demonstrated a significant reduction of <italic>MTAP</italic> in melanomas and metastases compared with nevi [<xref ref-type="bibr" rid="r22">22</xref>]. In addition, <italic>SOX4</italic> expression was reduced in metastatic malignant melanoma compared with dysplastic nevi and primary melanoma. <italic>SOX4</italic> downregulation was correlated with a poor prognosis and <italic>SOX4</italic>-depleted melanoma cells showed enhanced invasion and migration [<xref ref-type="bibr" rid="r23">23</xref>].</p>
      <p>SSH technique was previously used in efforts to identify genes that were differentially expressed in UM [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>]. One study was aiming to identify genes involved in the development of metastases [<xref ref-type="bibr" rid="r21">21</xref>] whereas the other studies were rather aiming to identify genes that are involved in malignant transformation of melanocytes [<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>]. Only a very small number of genes were reported by these studies as a result of the analysis of their subtracted library [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>]. As a consequence, an extensive comparison between our results and their data could not be performed. Among the four genes they reported, namely the cysteine-rich protein 61 (<italic>CYR61</italic>) and tissue factor (also called coagulation factor III), <italic>EDNRB</italic> and the AXL receptor tyrosine kinase (<italic>AXL</italic>), only <italic>EDNRB</italic> was identified in our UVM subtracted library [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>].</p>
      <p>One limitation of the present study is the use of only one primary UM cell line for the preparation of the SSH libraries. However, the validation of the SSH list of genes by microarray, semi-quantitative RTâPCR and western blot with primary tumor samples compensated for the use of only the TP31 cell line as starting material. It is noteworthy that the TP31 cell line is devoided of the <italic>GNAQ/GNA11</italic> mutations and that, consequently, the genes reported in the present study could allow to establish a new mechanism for early gene expression changes leading to malignant transformation and proliferation of uveal melanocytes. Consistent data have been obtained when comparing the SSH results with microarray data and RNA/protein extracts of primary UM tumors, suggesting that UM cell lines could represent good models for such analyses given the limited availability of primary UM tumor samples. Studying the function of these genes and their biologic pathways may lead to the development of new therapeutic options.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors would like to thank Dr. Dan Bergeron and Mrs. Marcelle Giasson for clinical follow-up data, and Drs. Daniel O. Black and Yvonne Molgat for the UM tumor samples. They are also grateful to the nurses Louise Monroe and Sylvie Marcoux from the Clinique des tumeurs oculaires du service dâophtalmologie du CHUL for the recruitment of patients, as well as the Banque dâYeux Nationale for providing human globes. The Banque dâYeux Nationale is partly supported by the RÃ©seau de Recherche en SantÃ© de la Vision. The authors are indebted to the Natural Sciences and Engineering Research Council of Canada (NSERC) and the RÃ©seau de Recherche en SantÃ© de la Vision for their financial support. S.L. and C.B.L. were holding scholarships from the Canadian Institutes of Health Research (CIHR) as well as from the Fonds de la Recherche en SantÃ© du QuÃ©bec (FRSQ). F.V. and M.G. were supported by scholarships from the CIHR and the FRSQ, respectively. M.M. was supported by an Undergraduate Student Research Award from NSERC.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landreville</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Agapova</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Harbour</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Emerging insights into the molecular pathogenesis of uveal melanoma.</article-title>
          <source>Future Oncol</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>629</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">18922120</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Onken</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Worley</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Tuscan</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Harbour</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.</article-title>
          <source>J Mol Diagn</source>
          <year>2010</year>
          <volume>12</volume>
          <fpage>461</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">20413675</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Raamsdonk</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Bezrookove</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gaugler</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Barsh</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Bastian</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.</article-title>
          <source>Nature</source>
          <year>2009</year>
          <volume>457</volume>
          <fpage>599</fpage>
          <lpage>602</lpage>
          <pub-id pub-id-type="pmid">19078957</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Raamsdonk</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Griewank</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Crosby</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Garrido</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Vemula</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wiesner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Obenauf</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Wackernagel</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bouvier</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sozen</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Baimukanova</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Heguy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dolgalev</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Khanin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Busam</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Speicher</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bastian</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Mutations in GNA11 in uveal melanoma.</article-title>
          <source>N Engl J Med</source>
          <year>2010</year>
          <volume>363</volume>
          <fpage>2191</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">21083380</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harbour</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Onken</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Roberson</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Worley</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Council</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Matatall</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Helms</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bowcock</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Frequent mutation of BAP1 in metastasizing uveal melanomas.</article-title>
          <source>Science</source>
          <year>2010</year>
          <volume>330</volume>
          <fpage>1410</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">21051595</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Velculescu</surname>
              <given-names>VE</given-names>
            </name>
            <name>
              <surname>Madden</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lash</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rago</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Beaudry</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Ciriello</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Dufault</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Ferguson</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Hermeking</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hiraldo</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Luderer</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Mathews</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Petroziello</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Polyak</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zawel</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kinzler</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
          <article-title>Analysis of human transcriptomes.</article-title>
          <source>Nat Genet</source>
          <year>1999</year>
          <volume>23</volume>
          <fpage>387</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">10581018</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diatchenko</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>YF</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Chenchik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moqadam</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lukyanov</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lukyanov</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gurskaya</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sverdlov</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Siebert</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1996</year>
          <volume>93</volume>
          <fpage>6025</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">8650213</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wan</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Sharp</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Poirier</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Wagaman</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Chambers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pyati</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hom</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Galindo</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Huvar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Erlander</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Cloning differentially expressed mRNAs.</article-title>
          <source>Nat Biotechnol</source>
          <year>1996</year>
          <volume>14</volume>
          <fpage>1685</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">9634852</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beliveau</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Berube</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rousseau</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pelletier</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Guerin</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Expression of integrin alpha5beta1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>2363</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">10892885</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>McCormick</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Ritch</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pelton-Henrion</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1993</year>
          <volume>34</volume>
          <fpage>2210</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">8505203</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McLean</surname>
              <given-names>IW</given-names>
            </name>
            <name>
              <surname>Foster</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Gamel</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Modifications of Callenderâs classification of uveal melanoma at the Armed Forces Institute of Pathology.</article-title>
          <source>Am J Ophthalmol</source>
          <year>1983</year>
          <volume>96</volume>
          <fpage>502</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">6624832</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="book">Landreville S, Vigneault F, Bergeron M, Leclerc S, Gaudreault M, Morcos M, Mouriaux F, Salesse C, GuÃ©rin SL. Suppression of 5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines. Pigment Cell Melanoma Res 2011.</mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Proulx</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Landreville</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guerin</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Salesse</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Integrin alpha5 expression by the ARPE-19 cell line: comparison with primary RPE cultures and effect of growth medium on the alpha5 gene promoter strength.</article-title>
          <source>Exp Eye Res</source>
          <year>2004</year>
          <volume>79</volume>
          <fpage>157</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">15325562</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaniolo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Desnoyers</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Leclerc</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Guerin</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Regulation of poly(ADP-ribose) polymerase-1 (PARP-1) gene expression through the post-translational modification of Sp1: a nuclear target protein of PARP-1.</article-title>
          <source>BMC Mol Biol</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>96</fpage>
          <pub-id pub-id-type="pmid">17961220</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piekny</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Maddox</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>The myriad roles of Anillin during cytokinesis.</article-title>
          <source>Semin Cell Dev Biol</source>
          <year>2010</year>
          <volume>21</volume>
          <fpage>881</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">20732437</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hall</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Todd</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Hyland</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>McDade</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Grabsch</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dattani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hillan</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>The septin-binding protein anillin is overexpressed in diverse human tumors.</article-title>
          <source>Clin Cancer Res</source>
          <year>2005</year>
          <volume>11</volume>
          <fpage>6780</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">16203764</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rusnak</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mertz</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Calcineurin: form and function.</article-title>
          <source>Physiol Rev</source>
          <year>2000</year>
          <volume>80</volume>
          <fpage>1483</fpage>
          <lpage>521</lpage>
          <pub-id pub-id-type="pmid">11015619</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buchholz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ellenrieder</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>An emerging role for Ca2+/calcineurin/NFAT signaling in cancerogenesis.</article-title>
          <source>Cell Cycle</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>16</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">17245111</pub-id>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reuter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sehrsam</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ludolph</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Volkel</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A novel calcineurin splice variant that modifies calcineurin activity.</article-title>
          <source>Eur J Biochem</source>
          <year>2001</year>
          <volume>268</volume>
          <fpage>5955</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">11722584</pub-id>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bolander</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>AgnarsdÃ³ttir</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>StrÃ¶mberg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ponten</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hesselius</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Uhlen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bergqvist</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas.</article-title>
          <source>Cancer Genomics Proteomics</source>
          <year>2008</year>
          <volume>5</volume>
          <fpage>293</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="pmid">19287070</pub-id>
        </element-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Damato</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Scholes</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Nunn</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Field</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Heighway</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.</article-title>
          <source>Br J Cancer</source>
          <year>2002</year>
          <volume>87</volume>
          <fpage>1308</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">12439722</pub-id>
        </element-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wild</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Vogt</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bataille</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ehret</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gantner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Landthaler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Klinkhammer-Schalke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hofstaedter</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bosserhoff</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.</article-title>
          <source>Exp Dermatol</source>
          <year>2010</year>
          <volume>19</volume>
          <fpage>e251</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">20500769</pub-id>
        </element-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jafarnejad</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Wani</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Martinka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion.</article-title>
          <source>Am J Pathol</source>
          <year>2010</year>
          <volume>177</volume>
          <fpage>2741</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">20952589</pub-id>
        </element-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Van Ginkel</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Gee</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Ahmadi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Subramanian</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ksander</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Meisner</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Albert</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Polans</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma.</article-title>
          <source>Arch Ophthalmol</source>
          <year>2002</year>
          <volume>120</volume>
          <fpage>1719</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">12470148</pub-id>
        </element-citation>
      </ref>
      <ref id="r25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Ginkel</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Gee</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Shearer</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Subramanian</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Albert</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Meisner</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Varnum</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Polans</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival.</article-title>
          <source>Cancer Res</source>
          <year>2004</year>
          <volume>64</volume>
          <fpage>128</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">14729616</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>